Option chain shows key data for Tryp Therapeutics Inc Ordinary Shares's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Tryp Therapeutics Inc Ordinary Shares.

Tryp Therapeutics Inc Ordinary Shares (OTC:TRYPF) Stock, Option Chain

Psychedelics deals (geralt, sergeitokmakov by Pixabay) (1)

Cannabis

Psychedelics

TRYPF

Tryp Therapeutics finalizes merger with Exopharm, prepares for ASX listing with strategic shareholder benefits. Explore merger details now!

Tryp Therapeutics Set To Finalize Merger With Exopharm, Announces Trading Halt Ahead Of ASX Listing

News

Penny Stocks

Markets

Interview

ATAI

CMND

CMPS

CYBN

DRUG

ENVB

GHRS

IXHL

MNMD

PSIL

SEEL

SILO

Psychedelics Developer Secures $100M In Series A Funding, Will Support MDMA Approval To Treat PTSD



Psyched: $100M For MDMA Therapy, VA Funds, 2024 Watchlist, Reform Updates And More

Regulations

Psychedelics biotech Tryp Therapeutics (OTCQB: TRYPF) is advancing its psilocybin-based portfolio through several recent milestones.

Tryp Therapeutics Explores Psilocybin&#39;s Potential In New Trials To Treat IBS And Fibromyalgia

Tryp Therapeutics Inc Ordinary Shares

UBS analyst Michael Lasser maintains Advance Auto Parts (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AAP#NYSE">AAP</a>) with a Neutral and raises the price target from $42 to $44.

Price Target

Analyst Ratings

UBS Maintains Neutral on Advance Auto Parts, Raises Price Target to $44

The United States has agreed to provide up to $6.6 billion in direct funding to Taiwan Semiconductor Manufacturing Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) to build advanced chip facilities in the U.S.
The deal aims to enhance domestic semiconductor production and bolster national security by reducing reliance on foreign suppliers, Barron's <a target="_blank" href="https://www.barrons.com/news/us-finalizes-up-to-6-6-bn-funding-for-chip-giant-tsmc-65252814" rel="noreferrer noopener">reports</a>.
The Biden administration announced that Taiwan Semiconductor's investment will attract $65 billion in private capital to establish three state-of-the-art plants in Arizona.
Also Read: <a target="_blank" href="https://www.benzinga.com/tech/24/11/41978712/asml-projects-revenue-surge-to-63-billion-by-2030-eyes-ai-and-chip-market-boom" rel="noreferrer noopener">ASML Projects Revenue Surge to $63 Billion by 2030, Eyes AI and Chip Market Boom</a>
The announcement comes just before President-elect Donald Trump assumes office. Trump had previously attacked Taiwan for allegedly undermining the U.S. chip industry and <a target="_blank" href="https://www.benzinga.com/government/regulations/24/11/41845483/taiwan-semiconductor-us-expansion-plans-unfazed-by-trump-win-report" rel="noreferrer noopener">criticized the U.S. Chips Act</a>.
The first of Taiwan Semiconductor's facilities will likely commence operations by early 2025, focusing on producing cutting-edge logic chips. These chips will power next-generation technologies, including 5G/6G smartphones, autonomous vehicles, and AI applications.
Early production at the Arizona plant reportedly matches the quality of Taiwan Semiconductor's facilities in Taiwan, showcasing <a target="_blank" href="https://www.benzinga.com/government/24/10/41545709/usa-scores-big-win-taiwan-semiconductor-arizona-plant-sees-good-production-yields" rel="noreferrer noopener">strong initial yields</a>.
Commerce Secretary Gina Raimondo told Barron's the importance of manufacturing these advanced chips domestically, emphasizing their role in AI, quantum computing, and military hardware.
The initiative aims to mitigate risks associated with overseas supply chains by producing these chips on U.S. soil, addressing a critical national security concern.
In addition to the direct funding, the U.S. government is extending up to $5 billion in proposed loans to support Taiwan Semiconductor's Arizona project.
The investment will likely generate approximately 6,000 direct manufacturing jobs. A senior U.S. official told Barron's that at least $1 billion of the allocated funding could be distributed to Taiwan Semiconductor this year, contingent on meeting specific milestones.
Meanwhile, Taiwan Semiconductor remains focused on consolidating its moat while diversifying its footprint beyond Taiwan as global governments dole out attractive subsidies.
The contract chipmaker has <a target="_blank" href="https://www.benzinga.com/markets/emerging-markets/24/11/41951575/taiwan-semi-boosts-advanced-chipmaking-with-record-euv-expansion-grabs-56-global-share" rel="noreferrer noopener">ramped up its</a> deployment of extreme ultraviolet (EUV) lithography systems, a vital technology in semiconductor production, even with the substantial expense involved.
Each EUV machine costs more than $100 million, making them some of the most costly assets in the chip manufacturing sector.
Industry analysts suggest that TSMC has significantly boosted its EUV capacity, increasing its share of global EUV installations from 50% in 2020 to 56% by 2023.
In Asia, Japan has also earmarked over $64.9 billion to <a target="_blank" href="https://www.benzinga.com/government/regulations/24/11/41939018/japan-increases-semiconductor-funding-as-us-trade-policies-pressure-taiwan-semiconductor" rel="noreferrer noopener">boost the semiconductor and AI</a> sectors. Taiwan Semiconductor is eyeing a second facility in Japan's Kumamoto region, considering a $13.5 billion investment after its first $8.6 billion wafer factory there.
Additionally, the company intends to establish a third advanced chip plant valued at $20 billion in Kumamoto to produce 3-nanometer chips.
Taiwan Semiconductor stock is up 86% year-to-date.
Price Actions: TSM stock is down 1.21% at $186.23 at the last check on Friday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/news/management/24/11/41978942/salesforce-ceo-marc-benioff-bets-big-on-billion-bots" target="_blank" rel="noreferrer noopener">Salesforce CEO Marc Benioff Bets Big on Billion Bots</a></li>
</ul>
Image via Shutterstock

Government

Tech

Media

Just Before Biden's Term Ends, Taiwan Semiconductor Lands $6.6 Billion in US Funding to Build Advanced Chip Plants

Truist Securities analyst Michael Lewis maintains American Healthcares (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AHR#NYSE">AHR</a>) with a Buy and raises the price target from $27 to $29.

Truist Securities Maintains Buy on American Healthcares, Raises Price Target to $29

Benchmark analyst Fawne Jiang reiterates Alibaba Gr Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>) with a Buy and maintains $118 price target.

Reiteration

BABA

Benchmark Reiterates Buy on Alibaba Gr Hldgs, Maintains $118 Price Target

<a href="https://www.bloomberg.com/news/articles/2024-11-15/xi-warns-against-going-back-in-history-as-trump-tariffs-loom">https://www.bloomberg.com/news/articles/2024-11-15/xi-warns-against-going-back-in-history-as-trump-tariffs-loom</a>
Chinese President Xi Jinping warned against any efforts to unwind globalization in his first major remarks since Donald Trump won the US presidential election after threatening to impose tariffs as high as 60% on the world's second-biggest economy.

Macro Economic Events

Economics

"Xi Warns Against 'Going Back in History' as Trump Tariffs Loom" - Bloomberg News

Truist Securities analyst Scott Ciccarelli maintains Advance Auto Parts (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AAP#NYSE">AAP</a>) with a Hold and lowers the price target from $41 to $39.

Truist Securities Maintains Hold on Advance Auto Parts, Lowers Price Target to $39

Benchmark analyst Michael Albanese reiterates OneWater Marine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONEW#NASDAQ">ONEW</a>) with a Hold.

ONEW

Benchmark Reiterates Hold on OneWater Marine

In a move likely to lighten the load for thousands of retirees in Florida, the state has introduced a new COLA to its property tax exemptions to help seniors cope with <a href="https://www.benzinga.com/real-estate/24/06/39229358/u-s-home-prices-surge-50-jump-in-five-years">rising housing costs</a>.&nbsp;
Currently, eligible homeowners receive two $25,000 exemptions, reducing the taxable value of their primary residence by up to $50,000. With this amendment, the second $25,000 exemption will now grow yearly to mirror inflation – much like Social Security's COLA increase.&nbsp;
Don't Miss:
<ul>
<li>‘Beating the market through ethical real estate investing' —<a href="https://www.benzinga.com/money/invest-with-roots"> this platform aims to give tenants equity in the homes they live in while scoring 17.38% average annual returns for investors – here&#8217;s how to join with just $100</a></li>
<li>This company is giving accredited investors an opportunity to invest in this $2 billion fund, <a href="https://www.benzinga.com/money/ignite-funding">with three decades in business they boast an impressive track record of double-digit returns.</a></li>
</ul>
For retirees feeling the pinch of inflated grocery, health care and utility costs, this tweak could mean real savings that help make ends meet.
Beginning Jan. 1, 2025, Florida&#8217;s homestead exemption – a property tax break on primary homes – will include an inflation-linked increase. In effect, the state will adjust part of the exemption amount annually to keep up with inflation, much like Social Security annually receives a COLA boost.&nbsp;
Trending: During market downturns, investors are learning that unlike equities, these<a href="https://www.benzinga.com/money/connect-invest-real-estate-notes"> high-yield real estate notes that pay 7.5% &#8211; 9% are protected by resilient assets, buffering against losses.</a>
By pegging this exemption to inflation, retirees will be protected against property tax increases, which can otherwise eat away at home equity and monthly budgets. The impact of such a policy can be huge. For example, the income limits for eligibility to exemptions rose 4.1% in 2024, widening the reach of the benefit and bringing more retirees under its umbrella.&nbsp;
Supporters see the amendment as a lifeline, especially in a state like Florida, where retirees comprise a significant portion of the population.&nbsp;
The passage of Amendment No. 5 was fueled in part by Florida's rapidly increasing housing costs. Housing prices in the state have shot up in recent years and property taxes that match these prices can quickly become untenable for those on fixed incomes.
See Also: This Jeff Bezos-backed startup will allow you to<a href="https://www.benzinga.com/money/bezos-landlord-100-dollars"> become a landlord in just 10 minutes, and you only need $100</a>.
On the flip side, not all Florida residents stand to benefit. Property tax relief remains out of reach for <a href="https://www.benzinga.com/real-estate/24/09/40669305/your-landlord-might-be-raising-rent-using-algorithms-and-kamala-harris-plans-to-ban-it-will-she-succ">landlords</a>, for instance, who don't qualify for the exemption. Moreover, some experts fear that as property tax revenue dips, the financial burden might eventually be shifted to nonexempt residents.
Florida's homestead exemption only applies to primary residences, meaning a property must serve as a person's permanent home to qualify for this exemption.&nbsp;
Amendment No. 5 includes a carve-out for schools, ensuring they won't see a dip in property tax revenue due to the new policy. However, all other local governments, such as fire departments and utilities, may need to make up for the shortfall in other ways.
Read Next:
<ul>
<li>Warren Buffett once said, "If you don't find a way to make money while you sleep, you will work until you die." <a href="https://www.benzinga.com/money/connect-invest-real-estate-notes">These high-yield real estate notes that pay 7.5% &#8211; 9% make earning passive income easier than ever.</a></li>
<li>These five entrepreneurs are worth $223 billion –<a href="https://www.benzinga.com/money/arrived-homes-private-credit-fund"> they all believe in one platform that offers a 7-9% target yield with monthly dividends</a></li>
</ul>

Real Estate

Florida Just Introduced A Property Tax COLA For Retirees – How This Boost Could Ease Housing Costs For Thousands

Truist Securities analyst David Macdonald maintains AdaptHealth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AHCO#NASDAQ">AHCO</a>) with a Buy and lowers the price target from $13 to $12.

AHCO

Truist Securities Maintains Buy on AdaptHealth, Lowers Price Target to $12

Benchmark analyst Josh Sullivan reiterates Ultralife (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULBI#NASDAQ">ULBI</a>) with a Buy and maintains $14 price target.

ULBI

Benchmark Reiterates Buy on Ultralife, Maintains $14 Price Target

<a href="https://www.reuters.com/world/europe/germanys-scholz-russias-putin-hold-phone-call-friday-bloomberg-reports-2024-11-15/" title="https://www.reuters.com/world/europe/germanys-scholz-russias-putin-hold-phone-call-friday-bloomberg-reports-2024-11-15/">https://www.reuters.com/world/europe/germanys-scholz-russias-putin-hold-phone-call-friday-bloomberg-reports-2024-11-15/</a>

Macro Notification

General

Putin And Germany's Scholz Hold Phone Call Initiated By Germany, Discuss Ukraine And Middle East; Putin Emphasizes Openness To Ukraine Talks, Notes Degradation In Russia-Germany Relations, And Stresses Security And Territorial Concerns

U.S. stocks were lower, with the Dow Jones index falling around 300 points on Friday.
Shares of Despegar.com, Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DESP#NYSE">DESP</a>) rose sharply during Friday's session after the company reported <a href="https://www.benzinga.com/quote/DESP/earnings">better-than-expected third-quarter sales.</a>
The company said it sees FY24 revenue of at least $760 million and adjusted EBITDA of at least $170 million
Despegar.com shares jumped 19.1% to $17.70 on Friday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Bloom Energy Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BE#NYSE">BE</a>) shares jumped 43% to $18.98. Bloom Energy announced a 1 GW fuel cell deal with AEP, providing clean power for AI Data Centers.</li>
<li>Red Cat Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCAT#NASDAQ">RCAT</a>) gained 22.3% to $4.9200.</li>
<li>Intuitive Machines, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUNR#NASDAQ">LUNR</a>) gained 13% to $11.56. The company reported third-quarter results on Thursday.</li>
<li>Century Aluminum Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CENX#NASDAQ">CENX</a>) rose 12.6% to $23.77.</li>
<li>COMPASS Pathways plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMPS#NASDAQ">CMPS</a>) jumped 12.5% to $5.50.</li>
<li>Lifeway Foods, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LWAY#NASDAQ">LWAY</a>) gained 11% to $24.85. The company reported quarterly results on Thursday.</li>
<li>Kingsoft Cloud Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KC#NASDAQ">KC</a>) rose 10.3% to $5.13. Kingsoft Cloud Holdings will release its unaudited financial results for the third quarter before the open of U.S. markets on Tuesday, Nov. 19.</li>
<li>Alcoa Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AA#NYSE">AA</a>) gained 7.7% to $44.40.</li>
<li>Zai Lab Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZLAB#NASDAQ">ZLAB</a>) shares rose 6.3% to $28.34. The company priced a $200 million public offering of 7,843,137 shares at $25.50 per ADS.</li>
<li>Palantir Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>) gained 6% to $62.72 after the company announced it will transfer its stock exchange listing over to the Nasdaq.</li>
<li>The Walt Disney Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>) rose 3% to $112.38. The company reported quarterly results on Thursday.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/24/11/42007586/top-4-energy-stocks-that-could-blast-off-in-november">Top 4 Energy Stocks That Could Blast Off In November</a></li>
</ul>

Earnings

Movers

Trading Ideas

CENX

DESP

LUNR

LWAY

PLTR

RCAT

ZLAB

Despegar.com, Zai Lab, Bloom Energy And Other Big Stocks Moving Higher On Friday

Options

DKNG

DraftKings Option Alert: Dec 20 $42 Calls At The Ask: 2000 @ $0.89 Vs 1254 OI; Ref=$39.23

WIIM

BNTX

MRNA

NVAX

VALN

Shares of vaccine stocks are trading lower After President-elect Trump nominated Robert F. Kennedy Jr. to lead the HHS.

Prime Minister Keir Starmer is seeking to meet with China&#39;s Xi Jinping at next week&#39;s Group of 20 summit in Rio de Janeiro, in what would be the first face-to-face encounter between British and Chinese leaders in almost seven years.&nbsp;
<a href="https://www.bloomberg.com/news/articles/2024-11-15/uk-s-starmer-seeks-xi-meeting-at-g-20-summit-in-rio-de-janeiro" title="https://www.bloomberg.com/news/articles/2024-11-15/uk-s-starmer-seeks-xi-meeting-at-g-20-summit-in-rio-de-janeiro">https://www.bloomberg.com/news/articles/2024-11-15/uk-s-starmer-seeks-xi-meeting-at-g-20-summit-in-rio-de-janeiro</a>

'UK's Starmer Seeks Xi Meeting at G-20 Summit in Rio de Janeiro' - Bloomberg

Wells Fargo analyst Eric Luebchow maintains Dycom Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DY#NYSE">DY</a>) with a Overweight and raises the price target from $200 to $215.

Wells Fargo Maintains Overweight on Dycom Industries, Raises Price Target to $215

Benchmark analyst Bill Sutherland reiterates HeartBeam (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BEAT#NASDAQ">BEAT</a>) with a Speculative Buy and maintains $8 price target.

BEAT

Benchmark Reiterates Speculative Buy on HeartBeam, Maintains $8 Price Target

Goldman Sachs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>) has dramatically increased its exposure to Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) ETFs, according to its latest 13F filing with the U.S. Securities and Exchange Commission (SEC), reflecting growing <a href="https://www.benzinga.com/24/11/42009965/vaneck-ceo-boldly-predicts-bitcoin-at-300k-per-coin-reaching-half-of-golds-market-cap-in-the-face-of-growing-demand">institutional interest in digital assets.</a>
What Happened: The Wall Street powerhouse <a href="https://www.sec.gov/edgar/search/#/q=Bitcoin&amp;dateRange=custom&amp;category=custom&amp;entityName=Goldman%2520Sachs&amp;startdt=2024-11-14&amp;enddt=2024-11-14&amp;forms=13F-HR">disclosed</a> $710 million invested across multiple Bitcoin exchange-traded funds (ETFs) for the quarter ending September 30. A 13F filing is a quarterly report required by the SEC for institutional investors managing over $100 million in assets.
<h3 class="wp-block-heading">Major Holdings in BlackRock's Bitcoin Trust</h3>
The filing highlights Goldman Sachs&#8217; significant stake in BlackRock's iShares Bitcoin Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBIT#NASDAQ">IBIT</a>), with 12.7 million shares valued at $461 million. 
This marks an 83% increase from its August holdings of 6.9 million shares, then valued at $281 million, and solidifies Goldman's position as the second-largest holder of IBIT, trailing only Millennium Management, which leads with $844 million in holdings.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42007247/bitcoin-dogecoin-success-driven-by-narrative-and-momentum-report-argues">Bitcoin, Dogecoin Success Driven By &#8216;Narrative And Momentum,&#8217; Report Argues</a>
<h3 class="wp-block-heading">Diversifying Bitcoin ETF Investments</h3>
Goldman also boosted its positions in other prominent Bitcoin ETFs. Notable increases include:
<ul>
<li>Fidelity's Wise Origin Bitcoin ETF (CBOE: FBTC): 1.7 million shares worth $95.5 million, a 13% rise.</li>
<li>Grayscale Bitcoin Trust (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GBTC#OTC">GBTC</a>): 1.4 million shares valued at $71.8 million, a 116% increase.</li>
<li>Bitwise Bitcoin ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BITB#NYSE">BITB</a>): 650,961 shares worth $22.5 million, marking a 156% rise.</li>
</ul>
The bank also reported smaller stakes in Bitcoin ETFs offered by Invesco Galaxy, WisdomTree and ARK 21Shares.
<h3 class="wp-block-heading">Institutional Confidence In A Booming Market</h3>
Goldman's expanded investments coincide with record inflows into <a href="https://www.benzinga.com/24/11/41869353/massive-day-for-blackrocks-bitcoin-etf-as-trading-volume-reaches-unseen-levels-with-4-1-billion-traded">spot Bitcoin ETFs.</a> BlackRock's IBIT recently surpassed the iShares Gold ETF (IAU) in net assets, an impressive milestone considering IBIT's launch occurred just this January.
The rising momentum aligns with broader market optimism for a <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41770352/bitcoins-future-under-president-elect-donald-trump-a-look-at-his-crypto-policies">pro-crypto regulatory environment</a> under the incoming Trump administration, which has pledged support for crypto mining and a <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41986427/pennsylvania-introduces-bitcoin-strategic-reserve-act-to-invest-up-to-700-million-in-btc">national Bitcoin reserve</a>.
Goldman's aggressive moves into Bitcoin ETFs underscore the shifting landscape for digital assets, signaling increasing institutional adoption of cryptocurrency as a mainstream asset class.
To explore these developments further, Benzinga's <a href="https://www.benzinga.com/events/digital-assets/agenda/">Future of Digital Assets</a> event on Nov. 19 offers in-depth insights into the evolving crypto investment landscape.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/legal/24/11/41996491/18-republican-states-sue-bidens-sec-over-harsh-crypto-crackdown">18 Republican States Sue Biden&#8217;s SEC Over Harsh Crypto Crackdown</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

Bitwise Bitcoin ETF Common Shares of Beneficial Interest

BITB

Fidelity Wise Origin Bitcoin Fund Fidelity Wise Origin Bitcoin Fund

FBTC

GBTC

IBIT

Goldman Sachs Expands Bitcoin ETF Holdings To $710 Million

Benchmark analyst Fawne Jiang reiterates JD.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JD#NASDAQ">JD</a>) with a Buy and maintains $47 price target.

Benchmark Reiterates Buy on JD.com, Maintains $47 Price Target

Jeffrey T Diehl, Director at Paylocity Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCTY#NASDAQ">PCTY</a>), executed a substantial insider sell on November 14, according to an SEC filing.
What Happened: Diehl's decision to sell 36,133 shares of Paylocity Holding was revealed in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0001591698/000159169824000334//Archives/edgar/data/1591698/000159169824000334/0001591698-24-000334-index.htm">U.S. Securities and Exchange Commission</a> on Thursday. The total value of the sale is $7,674,132.
The latest market snapshot at Friday morning reveals Paylocity Holding shares down by 0.3%, trading at $204.89.
<h3>All You Need to Know About Paylocity Holding</h3>
Paylocity is a provider of payroll and human capital management solutions servicing small- to midsize clients in the United States. The company was founded in 1997 and targets businesses with 10-5,000 employees and services about 39,000 clients as of fiscal 2024. Alongside core payroll services, Paylocity offers HCM solutions such as time and attendance and recruiting software as well as workplace collaboration and communication tools.
<h3>Unraveling the Financial Story of Paylocity Holding</h3>
Negative Revenue Trend: Examining Paylocity Holding's financials over 3 months reveals challenges. As of 30 September, 2024, the company experienced a decline of approximately -12.5% in revenue growth, reflecting a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Industrials sector.
Profitability Metrics: Unlocking Value
<ul>
<li>
Gross Margin: The company excels with a remarkable gross margin of 68.05%, indicating superior cost efficiency and profitability compared to its industry peers.
</li>
<li>
Earnings per Share (EPS): Paylocity Holding's EPS lags behind the industry average, indicating concerns and potential challenges with a current EPS of 0.62.
</li>
</ul>
Debt Management: With a below-average debt-to-equity ratio of 0.34, Paylocity Holding adopts a prudent financial strategy, indicating a balanced approach to debt management.
Assessing Valuation Metrics:
<ul>
<li>
Price to Earnings (P/E) Ratio: With a lower-than-average P/E ratio of 61.16, the stock indicates an attractive valuation, potentially presenting a buying opportunity.
</li>
<li>
Price to Sales (P/S) Ratio: With a relatively high Price to Sales ratio of 8.65 as compared to the industry average, the stock might be considered overvalued based on sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): Boasting an EV/EBITDA ratio of 34.77, Paylocity Holding demonstrates a robust market valuation, outperforming industry benchmarks.
</li>
</ul>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Delving Into the Significance of Insider Transactions</h3>
Insightful as they may be, insider transactions should be considered alongside a thorough examination of other investment criteria.
From a legal standpoint, the term "insider" pertains to any officer, director, or beneficial owner holding more than ten percent of a company's equity securities as outlined in Section 12 of the Securities Exchange Act of 1934. This encompasses executives in the c-suite and significant hedge funds. These insiders are mandated to inform the public of their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
A company insider's new purchase is a indicator of their positive anticipation for a rise in the stock.
While insider sells may not necessarily reflect a bearish view and can be motivated by various factors.
<h3>A Closer Look at Important Transaction Codes</h3>
<a href="https://www.benzinga.com/money/investing-tools">Investors</a> prefer focusing on transactions that take place in the open market, indicated in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S indicates a sale. Transaction code C indicates the conversion of an option, and transaction code A indicates grant, award or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001591698">Check Out The Full List Of Paylocity Holding's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;utm_source=benzinga-insights">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insider Trades

PCTY

Paylocity Holding Director Trades $7.67M In Company Stock

Tryp Therapeutics signs of definitive agreement with Exopharm

Tryp Therapeutics Inc (TSE:TRYP) has released an update. Tryp Therapeutics Inc. shareholders have resoundingly supported an arrangement with Exopha...

Tryp Therapeutics Shareholders Approve Major Deal

Tryp Therapeutics Inc (TSE:TRYP) has released an update. Tryp Therapeutics Inc. has announced the approval of their arrangement with Exopharm Limit...

Tryp Therapeutics Moves Forward with Exopharm Merger

Tryp Therapeutics Inc (TSE:TRYP) has released an update. Tryp Therapeutics, Inc. has been acquired by Exopharm Limited through an all-stock transac...

Tryp Therapeutics Acquired by Exopharm

Offerings

Press Releases

Tryp Therapeutics Announces Closing of Oversubscribed Private Placement of Unsecured Convertible Notes for Gross Proceeds of AUD$3,215,000

Tryp Therapeutics Inc. Announces Signing of Definitive Agreement with Exopharm Limited

Tryp Therapeutics Announces First Patient Dosed in Phase 2a Clinical Trial for the Treatment of Fibromyalgia at The University of Michigan

Tryp Therapeutics Announces Significant Milestone in Its Clinical Trial Program for Trp-8803 (IV-infused Psilocin)

Biotech

Legal

Tryp Therapeutics Obtains Interim Order for Plan of Arrangement and Provides Details of Shareholder Meeting

Tryp Therapeutics Announces 99.92% Votes Cast by Shareholders in Favor of Arrangement Agreement at Annual General and Special Meeting of Securityholders, and Receipt of Final Order

Comments

Tryp Therapeutics Inc Ordinary Shares

Tryp Therapeutics Inc Ordinary Shares (TRYPF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga